GNRH1 and Dravet syndrome: Furthermore, a randomized pilot study [52], still in the recruitment phase, is being conducted to evaluate the efficacy of therapy with gonadotrophin-releasing hormone (GnRH), a decapeptide secreted by hypothalamic neurons, on the cognition of people with DS.